Renaissance Technologies’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $471K | Sell |
581,800
-74,900
| -11% | -$60.6K | ﹤0.01% | 2862 |
|
|
2025
Q1 | $504K | Buy |
656,700
+22,200
| +3% | +$17.1K | ﹤0.01% | 2739 |
|
|
2024
Q4 | $809K | Buy |
634,500
+437,600
| +222% | +$558K | ﹤0.01% | 2602 |
|
|
2024
Q3 | $408K | Sell |
196,900
-9,700
| -5% | -$20.1K | ﹤0.01% | 2869 |
|
|
2024
Q2 | $787K | Sell |
206,600
-38,200
| -16% | -$146K | ﹤0.01% | 2454 |
|
|
2024
Q1 | $1.16M | Buy |
244,800
+28,400
| +13% | +$135K | ﹤0.01% | 2393 |
|
|
2023
Q4 | $924K | Buy |
216,400
+77,026
| +55% | +$329K | ﹤0.01% | 2457 |
|
|
2023
Q3 | $431K | Sell |
139,374
-43,926
| -24% | -$136K | ﹤0.01% | 2779 |
|
|
2023
Q2 | $825K | Buy |
183,300
+44,800
| +32% | +$202K | ﹤0.01% | 2583 |
|
|
2023
Q1 | $789K | Buy |
138,500
+2,000
| +1% | +$11.4K | ﹤0.01% | 2625 |
|
|
2022
Q4 | $824K | Sell |
136,500
-6,900
| -5% | -$41.7K | ﹤0.01% | 2650 |
|
|
2022
Q3 | $948K | Sell |
143,400
-17,086
| -11% | -$113K | ﹤0.01% | 2533 |
|
|
2022
Q2 | $838K | Buy |
160,486
+120,386
| +300% | +$629K | ﹤0.01% | 2828 |
|
|
2022
Q1 | $277K | Sell |
40,100
-87,100
| -68% | -$602K | ﹤0.01% | 3506 |
|
|
2021
Q4 | $1.58M | Buy |
+127,200
| New | +$1.58M | ﹤0.01% | 2335 |
|